CRISPR Therapeutics AG

CRSP · Healthcare · · USD

55.79 USD

0.00 (-1.24%)

● Updated 2026-09-07 20:38 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 75

Trend & RS 69

Momentum 66

Fundamental 49

Macro 64

Liquidity 34

Component	Score	Weight
Technical	75.0	20%
Trend & RS	69.4	30%
Momentum	65.8	15%
Fundamental	49.4	10%
Macro	64.4	20%
Liquidity	33.5	5%

Trade Setup

Entry	55.79
Stop Loss	50.69 (9.1%)
Target 1 (1:1)	60.89 (+9.1%)
Target 2 (2:1)	65.99 (+18.3%)

ATR(14)	2.55 (4.6%)
Risk per Share	5.10
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	72.8	+0.91
Momentum	65.8	+0.63
Quality	40.0	-0.40
Composite	59.5

Quality Scores

Piotroski F-Score 3 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 3.27 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	3.1	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

42.79%

Full Kelly

21.39%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 65/100. Estimated win rate 60%, avg win 8.9%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

50.7

RSI(14)

1.1944

MACD

Relative Strength (RS) NEUTRAL

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (+2.9% vs SPY 3M)
RS vs Sector	INLINE (Healthcare)
RS New High	No (44d since high)
Sector Outperformance	-0.1% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

Indicator	Value	Signal
Rsi	50.7	NEUTRAL
Macd	1.1944	BEARISH
Ma Cross	53.76 / 53.24	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.63x	NORMAL

Key Levels

Level	Price
52-Week High	78.48
Bollinger Upper	61.45
SMA(200)	53.24
SMA(50)	53.76
SMA(20)	56.55
Current Price	55.79
Bollinger Lower	51.66
52-Week Low	44.12
ATR(14)	2.55

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION A Confidence

33%

Selling Climax Buying Climax

Acc: 2.0 | Dist: 2.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	0.98x	Normal bar — no special VSA pattern
2026-09-01	Normal	0.62x	Normal bar — no special VSA pattern
2026-09-02	Normal	0.64x	Normal bar — no special VSA pattern
2026-09-03	Normal	1.04x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.63x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	58.45	Above Kijun
Kijun-sen (26)	54.92	Base line
Senkou A	56.69	Leading span A
Senkou B	54.67	Leading span B
Cloud	54.67 – 56.69	Bullish (Green)
Price vs Cloud	55.79	Inside Cloud
Chikou Span	47.99	Bullish
Alignment Score	3/4	NEUTRAL